Millennium Pharmacon International Tbk (SDPC)
IDX
192.00
0.00 (0.00%)
Real-time Data
02:00 AM
Day's Range
188.00226.00
52 wk Range
126.00228.00
Financial Statements - SDPC - Millennium Pharmacon International Tbk
Revenue
4.10T▲ 4.9%
Net Income
38.46B▲ 127.4%Net Margin 0.9%
EBITDA
137.22B▲ 14.3%
Free Cash Flow
38.99B▲ 127.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.10T | 3.91T | 3.36T | 3.20T | 2.98T | 2.64T |
| Cost of Goods | 3.74T | 3.58T | 3.07T | 2.93T | 2.74T | 2.42T |
| Gross Profit | 362.35B | 334.37B | 292.34B | 269.63B | 241.75B | 221.69B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 113.53B | 96.43B | 109.04B | 81.20B | 68.83B | 53.77B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 48.89B | 27.70B | 47.96B | 36.46B | 17.92B | 7.73B |
| Income Tax | 10.43B | 10.78B | 14.87B | 12B | 8.35B | 4.93B |
| Net Income | 38.46B | 16.91B | 33.08B | 24.46B | 9.57B | 2.80B |
| EPS Basic | 30.2 | 13.29 | 25.97 | 19.2 | 7.51 | 2.2 |
| EPS Diluted | 30.2 | 13.29 | 25.97 | 19.2 | 7.51 | 2.2 |
| Basic Shares Outstanding | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B |
| Diluted Shares Outstanding | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B |
| Ebit | 113.82B | 96.49B | 105.53B | 74.94B | 57.81B | 52.85B |
| Ebitda | 137.22B | 120.06B | 128.15B | 98.72B | 84.69B | 69.34B |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | 2.66M | 14.74M | 6.32M | 0 | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
